RTA 402

bardoxolone methyl · Reata Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RTA 402, covering 2012-07-30 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma [Phase 2]